Anticoagulant therapy can be administered to VWD patients, but it should always be accompanied by replacement therapy to maintain adequate levels of von Willebrand factor (VWF) and factor VIII (FVIII). The gene discussed is VWF; the disease is von Willebrand disease (hereditary or acquired).